IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.300
EU - Europa 3.769
AS - Asia 2.624
SA - Sud America 316
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 11.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.242
SG - Singapore 1.101
CN - Cina 798
IT - Italia 711
IE - Irlanda 674
SE - Svezia 515
UA - Ucraina 510
TR - Turchia 355
DE - Germania 349
GB - Regno Unito 311
BR - Brasile 292
FR - Francia 238
FI - Finlandia 182
IN - India 141
RU - Federazione Russa 114
KR - Corea 86
VN - Vietnam 43
AT - Austria 39
HK - Hong Kong 39
CA - Canada 36
NL - Olanda 27
BE - Belgio 18
CZ - Repubblica Ceca 17
RO - Romania 14
AR - Argentina 11
BD - Bangladesh 10
MX - Messico 10
CH - Svizzera 9
ES - Italia 8
EC - Ecuador 7
IQ - Iraq 6
PL - Polonia 6
LT - Lituania 5
TW - Taiwan 5
AZ - Azerbaigian 4
EU - Europa 4
HR - Croazia 4
IL - Israele 4
EE - Estonia 3
JP - Giappone 3
PK - Pakistan 3
PS - Palestinian Territory 3
VE - Venezuela 3
ZA - Sudafrica 3
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.028
Salva come PNG Salva come JPEG
Città #
Singapore 804
Chandler 780
Jacksonville 696
Dublin 657
Princeton 318
Southend 244
Nanjing 215
Izmir 195
Ashburn 184
The Dalles 166
Altamura 141
Santa Clara 140
Munich 126
Chieti 111
Beijing 109
Dearborn 108
Wilmington 104
Cambridge 97
Ann Arbor 87
Tongling 82
Boardman 74
Nanchang 65
Pescara 56
Los Angeles 53
Helsinki 45
New York 39
Hong Kong 38
Shenyang 37
Nuremberg 35
Rome 35
Pune 32
Dong Ket 30
Seattle 28
Tianjin 28
Turku 28
Washington 28
Hebei 27
Jiaxing 25
Kunming 24
São Paulo 24
Woodbridge 24
Dallas 22
Milan 21
Changsha 20
Hangzhou 20
Brussels 17
Brooklyn 16
Grevenbroich 16
Norwalk 16
Toronto 16
Frankfurt am Main 15
Jinan 14
San Francisco 14
Changchun 13
Espoo 13
Augusta 12
Moscow 12
Vienna 12
Brno 11
London 11
Falls Church 9
Rio de Janeiro 9
Chicago 8
Guangzhou 8
Lanzhou 8
Lappeenranta 8
Orange 8
San Mateo 8
San Vito Chietino 8
Tappahannock 8
Ningbo 7
Salvador 7
Brasília 6
Curitiba 6
Edinburgh 6
Houston 6
Lille 6
Montreal 6
Ascoli Piceno 5
Atlanta 5
Bari 5
Boston 5
Düsseldorf 5
Hefei 5
Ho Chi Minh City 5
Mexico City 5
Olomouc 5
Porto Alegre 5
Shanghai 5
Taipei 5
Albenga 4
Andover 4
Aparecida de Goiânia 4
Aquila 4
Auburn Hills 4
Baku 4
Belo Horizonte 4
Chennai 4
Hyderabad 4
Leawood 4
Totale 6.662
Salva come PNG Salva come JPEG
Nome #
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 127
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 127
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 120
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 114
Metabolic modifications in HIV-infected women 111
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 110
Relevance of plant lectins in human cell biology and immunology 110
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 109
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 107
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 106
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 105
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 103
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 103
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 101
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 101
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 101
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 101
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 98
Acute urinary retention due to HSV-1: a case report 98
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 98
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 97
Inguinal lymphadenopathy due to Bartonella henselae 97
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 96
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 96
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 95
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 94
Canakinumab in a subgroup of patients with COVID-19 94
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 93
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 92
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 92
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 91
IL-1beta induces alkaline phosphatase in human phagocytes 90
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 90
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 89
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 89
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 87
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 87
Is the rate of virological failure to cART continuing to decline in recent calendar years? 87
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 86
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 86
Normal breathing releases SARS-CoV-2 into the air 86
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 86
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 85
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 85
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 84
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 84
Proteinuria in an African HIV-infected patient: effects of telmisartan. 84
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 83
High dose of erythropoietin in management of interferon/ribavirin induced anemia 81
Antiretroviral therapy management and rationalisation of available resources 81
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 80
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 80
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 80
Hypertension in HIV: Management and Treatment 78
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 78
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 78
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 78
Periodontitis and cytokine patterns in HIV positive patients 77
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 77
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 77
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 77
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 76
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 76
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 76
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 75
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 75
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 75
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 75
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 75
Interleukin-31: a new cytokine involved in inflammation of the skin 74
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 74
Infected atrial mixoma: a rare cause of fever 73
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 73
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 73
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 73
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 72
Ruolo delle citochine nella patogenesi delle malattie infettive 71
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 71
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 71
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 71
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 71
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 70
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 70
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 70
Probiotics and anti-inflammatory processes in HIV infection: from Benchside Research to Bedside 70
Esophagitis and anticonvulsant hypersensitivity syndrome. 69
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 69
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 69
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 69
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 68
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 68
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 68
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 67
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 66
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. 65
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 65
Pidotimod and Immunological Activation in Individuals Infected with HIV 65
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 65
Evaluation of Cell Migration and Cytokines Expression Changes under the Radiofrequency Electromagnetic Field on Wound Healing In Vitro Model 65
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 64
Totale 8.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021859 122 6 153 18 73 170 33 24 57 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/2026209 209 0 0 0 0 0 0 0 0 0 0 0
Totale 11.815